Skip to main content
. 2022 Jul 22;94(11):5103–5111. doi: 10.1002/jmv.27994

Figure 1.

Figure 1

Schematic diagram of potential mechanisms for Kaposi's sarcoma‐associated herpesvirus (KSHV) reactivation by SARS‐CoV‐2 coinfection or anti‐COVID‐19 drugs. The arrows and bars represent the activation and inhibition, respectively. Notably, the mechanisms of KSHV regulation of angiotensin‐converting enzyme 2 expression remain unknown. N, nucleocapsid protein; S, spike protein.